{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:36:35Z","timestamp":1767990995237,"version":"3.49.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jinf.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T16:04:14Z","timestamp":1390838654000},"page":"507-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Micafungin for the treatment of invasive aspergillosis"],"prefix":"10.1016","volume":"68","author":[{"given":"D.A.","family":"Enoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.F.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Aliyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Karas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jinf.2014.01.007_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib5","first-page":"121","article-title":"In\u00a0vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature","volume":"20","author":"Espinel-Ingroff","year":"2003","journal-title":"Rev Iberoam Micol"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000057666","article-title":"In\u00a0vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds","volume":"48","author":"Nakai","year":"2002","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jmicro\/dfh100","article-title":"Effects of micafungin on the morphology of Aspergillus fumigatus","volume":"54","author":"Nishiyama","year":"2005","journal-title":"J Electron Microsc (Tokyo)"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant","volume":"49","author":"Hiemenz","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/AAC.01386-08","article-title":"Bronchopulmonary disposition of micafungin in healthy adult volunteers","volume":"53","author":"Nicasio","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.jinf.2014.01.007_bib10","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.05193-11","article-title":"Fractal geometry and the pharmacometrics of micafungin in overweight, obese and extremely obese people","volume":"55","author":"Hall","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.jinf.2014.01.007_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1248\/yakushi.127.897","article-title":"Pharmacokinetics of antifungal agent micafungin in critically ill patients receiving continuous hemodialysis filtration","volume":"127","author":"Hirata","year":"2007","journal-title":"Yakugaku Zasshi"},{"issue":"7","key":"10.1016\/j.jinf.2014.01.007_bib12","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.transproceed.2010.04.030","article-title":"Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation","volume":"42","author":"Fukuoka","year":"2010","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.5414\/CP201738","article-title":"Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Inoue","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/bmc.2822","article-title":"Simple column-switching HPLC method for determining levels of the antifungal agent micafungin in human plasma and application to patient samples","volume":"27","author":"Nakagawa","year":"2013","journal-title":"Biomed Chromatogr"},{"issue":"7","key":"10.1016\/j.jinf.2014.01.007_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.38.7.1480","article-title":"Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase","volume":"38","author":"Kurtz","year":"1994","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2014.01.007_bib16","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.47.8.2640-2643.2003","article-title":"Comparison of two methods and three end points in determination of in\u00a0vitro activity of micafungin against Aspergillus spp.","volume":"47","author":"Arikan","year":"2003","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/AAC.00699-07","article-title":"Comparative in\u00a0vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia","volume":"52","author":"Antachopoulos","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib18","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/AAC.49.12.5157-5159.2005","article-title":"Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani","volume":"49","author":"Heyn","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib19","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/JCM.41.12.5683-5688.2003","article-title":"New methods to assess susceptibilities of Aspergillus isolates to caspofungin","volume":"41","author":"Imhof","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2012.01.006","article-title":"Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.","volume":"73","author":"Martos","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/13693781003586943","article-title":"Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins","volume":"48","author":"Martos","year":"2010","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib22","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/AAC.01589-06","article-title":"Effects of serum on in\u00a0vitro susceptibility testing of echinocandins","volume":"51","author":"Odabasi","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib23","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/AAC.01536-06","article-title":"Serum differentially alters the antifungal properties of echinocandin drugs","volume":"51","author":"Paderu","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib24","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.01543-08","article-title":"Activity profile in\u00a0vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds","volume":"53","author":"Cuenca-Estrella","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib25","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1128\/AAC.01491-10","article-title":"Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece","volume":"55","author":"Arabatzis","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.jinf.2014.01.007_bib27","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkg185","article-title":"Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in\u00a0vivo resistance to amphotericin B","volume":"51","author":"Warn","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2014.01.007_bib29","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1080\/13693780400029023","article-title":"Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin","volume":"43","author":"Gardiner","year":"2005","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib30","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/AAC.00917-07","article-title":"A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus","volume":"51","author":"Rocha","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib31","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.00190-08","article-title":"Establishing in\u00a0vitro-in\u00a0vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins","volume":"52","author":"Arendrup","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib32","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jinf.2007.08.003","article-title":"Mould breakthrough in immunosuppressed adults receiving anidulafungin: a report of 2 cases","volume":"55","author":"Wetzstein","year":"2007","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.44.3.619-621.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis","volume":"44","author":"Matsumoto","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib35","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.46.6.1857-1869.2002","article-title":"Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits","volume":"46","author":"Petraitis","year":"2002","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib36","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1128\/AAC.49.12.4867-4875.2005","article-title":"Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis","volume":"49","author":"Clemons","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib37","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/AAC.00715-08","article-title":"Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis","volume":"52","author":"Lewis","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib38","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jac\/dkn069","article-title":"Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis","volume":"61","author":"Lewis","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1179\/joc.2011.23.2.102","article-title":"Evaluation of amphotericin B and micafungin combination against clinical isolates of Aspergillus species","volume":"23","author":"Nishi","year":"2011","journal-title":"J Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijantimicag.2008.05.015","article-title":"In\u00a0vitro interactions of itraconazole and micafungin against clinically important filamentous fungi","volume":"32","author":"Ruiz-Cendoya","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/jac\/dki343","article-title":"Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in\u00a0vitro","volume":"56","author":"Lewis","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib42","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/AAC.45.12.3310-3321.2001","article-title":"Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus","volume":"45","author":"Chiou","year":"2001","journal-title":"Antimicrobial Agents Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1469-0691.2004.00996.x","article-title":"In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus","volume":"10","author":"Ganesan","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib44","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.01007-06","article-title":"Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in\u00a0vitro using a novel response surface paradigm","volume":"51","author":"Brun","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/13693786.2010.530300","article-title":"In\u00a0vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods","volume":"49","author":"Ben-Ami","year":"2011","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/AAC.50.2.422-427.2006","article-title":"Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox\u2212\/\u2212 mouse model of chronic granulomatous disease","volume":"50","author":"Dennis","year":"2006","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib47","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/AAC.47.4.1452-1455.2003","article-title":"Efficacy of micafungin alone or in combination against systemic murine aspergillosis","volume":"47","author":"Luque","year":"2003","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib48","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1086\/375420","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin","volume":"187","author":"Petraitis","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jac\/dkl236","article-title":"Efficacy of Abelcet\u00a0alone, or in combination therapy, against experimental central nervous system aspergillosis","volume":"58","author":"Clemons","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13693780500148350","article-title":"Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis","volume":"44","author":"Clemons","year":"2006","journal-title":"Med Mycol"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1469-0691.2004.00958.x","article-title":"Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis","volume":"10","author":"Chandrasekar","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jac\/dkg425","article-title":"Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin","volume":"52","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2014.01.007_bib53","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AAC.01554-09","article-title":"Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections","volume":"54","author":"Olson","year":"2010","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2014.01.007_bib54","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00285-09","article-title":"Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis","volume":"53","author":"Takazono","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib55","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.01577-10","article-title":"Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins","volume":"55","author":"Ibrahim","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib56","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"Izumikawa","year":"2007","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.jinf.2014.01.007_bib58","first-page":"688","article-title":"Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study","volume":"49","author":"Kohno","year":"2011","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib59","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis","volume":"32","author":"Kohno","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jinf.2006.03.003","article-title":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","volume":"53","author":"Denning","year":"2006","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-3062.2008.00349.x","article-title":"Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"11","author":"Kontoyiannis","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib63","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10156-012-0391-x","article-title":"The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma","volume":"18","author":"Fujita","year":"2012","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10156-011-0219-0","article-title":"Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report","volume":"17","author":"Hanadate","year":"2011","journal-title":"J Infect Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib65","first-page":"128","article-title":"Clinical efficacy and safety of micafungin, a novel echinocandin antifungal drug in pulmonary aspergillosis in a postmarketing setting","volume":"58","author":"Kohno","year":"2010","journal-title":"Jpn J Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2169\/internalmedicine.45.1498","article-title":"Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia","volume":"45","author":"Yanada","year":"2006","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2169\/internalmedicine.46.6021","article-title":"Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies","volume":"46","author":"Toubai","year":"2007","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib68","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.21858","article-title":"Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies","volume":"85","author":"Goto","year":"2010","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clinthera.2010.04.005","article-title":"Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis","volume":"32","author":"Kubiak","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2014.01.007_bib70","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2014.01.007_bib71","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifield","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib72","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00277-011-1277-1","article-title":"Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study","volume":"90","author":"Yamaguchi","year":"2011","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib73","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00277-011-1316-y","article-title":"Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders","volume":"91","author":"Yoshida","year":"2012","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib74","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/10428194.2012.729057","article-title":"Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics","volume":"54","author":"Racil","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jinf.2014.01.007_bib75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12185-013-1396-7","article-title":"Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study","volume":"98","author":"Mizuno","year":"2013","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-007-0011-1","article-title":"Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation","volume":"87","author":"Hashino","year":"2008","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib77","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12185-008-0196-y","article-title":"Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation","volume":"88","author":"Hiramatsu","year":"2008","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib78","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/10428191003682726","article-title":"Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies","volume":"51","author":"Hirata","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib79","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00148581-200911040-00006","article-title":"Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients","volume":"11","author":"Carter","year":"2009","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/2047-783X-16-4-167","article-title":"Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin: review of the literature","volume":"16","author":"Glockner","year":"2011","journal-title":"Eur J Med Res"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2014.01.007_bib82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0213-005X(11)70009-X","article-title":"Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?","volume":"29","author":"Salavert","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib83","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.bbmt.2012.03.014","article-title":"Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant","volume":"18","author":"Huang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2014.01.007_bib84","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients of micafungin","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2014.01.007_bib85","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/INF.0b013e3182127eaf","article-title":"Safety of micafungin in pediatric clinical trials","volume":"30","author":"Arrieta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib86","first-page":"345","article-title":"Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials","volume":"125","author":"Chen","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2014.01.007_bib88","series-title":"Funguard prescribing information","author":"Astellas Pharma Inc.","year":"2013"},{"issue":"2","key":"10.1016\/j.jinf.2014.01.007_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13693780802262123","article-title":"Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan","volume":"47","author":"Ikeda","year":"2009","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.jinf.2014.01.007_bib90","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.00428-11","article-title":"In\u00a0vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2014.01.007_bib91","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/AAC.49.8.3495-3497.2005","article-title":"Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation","volume":"49","author":"Guinea","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib92","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1128\/JCM.01550-06","article-title":"Determination of MICs of aminocandin for Candida spp. and filamentous fungi","volume":"44","author":"Isham","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.jinf.2014.01.007_bib93","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/JCM.00328-10","article-title":"Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008)","volume":"48","author":"Messer","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib94","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In\u00a0vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrobial Agents Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib95","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.01155-09","article-title":"In\u00a0vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2010.08.013","volume":"69","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In\u00a0vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib98","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.7164\/antibiotics.53.1175","article-title":"In\u00a0vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens","volume":"53","author":"Uchida","year":"2000","journal-title":"J Antibiot (Tokyo)"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib99","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diagmicrobio.2011.08.006","article-title":"In\u00a0vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"71","author":"Rudramurthy","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib100","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","article-title":"In\u00a0vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs","volume":"54","author":"Shivaprakash","year":"2011","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.jinf.2014.01.007_bib101","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2169\/internalmedicine.46.6193","article-title":"Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in\u00a0vitro susceptibility of A. terreus isolate to micafungin","volume":"46","author":"Tokimatsu","year":"2007","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In\u00a0vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","author":"Alastruey-Izquierdo","year":"2010","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib103","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.inf.0000258698.98370.89","article-title":"Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin","volume":"26","author":"Santos","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.jinf.2014.01.007_bib104","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.transproceed.2007.05.085","article-title":"A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation","volume":"39","author":"Takeda","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/00365540600951333","article-title":"A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid","volume":"39","author":"Okugawa","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib106","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10156-007-0524-9","article-title":"Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin","volume":"13","author":"Ouchi","year":"2007","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib107","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12185-010-0556-2","article-title":"Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug","volume":"91","author":"Yamada","year":"2010","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib108","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.joms.2006.01.019","article-title":"Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report","volume":"64","author":"Myoken","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib109","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1532\/IJH97.03163","article-title":"Successful micafungin (FK463) treatment of invasive pulmonary aspergillosis in a patient with acute lymphoblastic leukemia in a phase II study","volume":"79","author":"Ota","year":"2004","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2014.01.007_bib110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00431-006-0224-y","article-title":"X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation","volume":"166","author":"Kobayashi","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.jinf.2014.01.007_bib111","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00277-003-0736-8","article-title":"Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy","volume":"83","author":"Yokote","year":"2004","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib112","first-page":"160","article-title":"Mycotic aneurysm of the distal aortic arch caused by Aspergillus","volume":"54","author":"Hosono","year":"2006","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.jinf.2014.01.007_bib113","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2169\/internalmedicine.49.2860","article-title":"A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid","volume":"49","author":"Matsuda","year":"2010","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.jinf.2014.01.007_bib114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7883\/yoken.JJID.2008.379","article-title":"A case of Legionella pneumophila pneumonia followed by invasive aspergillosis","volume":"61","author":"Saijo","year":"2008","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.01.007_bib115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10156-011-0339-6","article-title":"Iliopsoas abscess caused by Aspergillus fumigatus complicated by pulmonary aspergillosis","volume":"18","author":"Yoshida","year":"2012","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:19:11Z","timestamp":1759007951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445314000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0163445314000139"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2014.01.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micafungin for the treatment of invasive aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}